Purchases and Sales Made in Q1 2024 in Dyne Therapeutics, Inc. (DYN)
This table provides information about the institutional ownership of Dyne Therapeutics, Inc. (DYN) during Q1 2024. The information is specifically focused on institutions that hold shares of Dyne Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Algert Global LLC
San Francisco, CA |
SELL
|
- |
-134K- 82.97% |
$1.74M - $3.9M
|
27.4K
$258K
|
|
|
May 15, 2024
Q1 2024
|
Logos Global Management LP
San Francisco, CA |
SELL
|
- |
-150K- 7.98% |
$1.96M - $4.38M
|
1.73M
$16.3M
|
|
|
Dec 06, 2024
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-171K- 69.02% |
$2.24M - $5M
|
76.9K
$723K
|
|
|
Feb 07, 2025
Q1 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-171K- 69.02% |
$2.24M - $5M
|
76.9K
$723K
|
|
|
May 15, 2024
Q1 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-208K- 32.29% |
$2.71M - $6.06M
|
435K
$4.09M
|
|
|
May 15, 2024
Q1 2024
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-272K- 49.38% |
$3.55M - $7.93M
|
279K
$2.62M
|
|
|
Jun 02, 2025
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-291K- 91.48% |
$3.8M - $8.48M
|
27.1K
$255K
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-370K- 95.36% |
$4.83M - $10.8M
|
18K
$169K
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-479K- 59.45% |
$6.25M - $14M
|
327K
$3.07M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.06M- 52.4% |
$13.8M - $30.9M
|
962K
$9.04M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.06M- 52.4% |
$13.8M - $30.9M
|
962K
$9.04M
|
|
|
Apr 18, 2024
Q1 2024
|
Wasatch Advisors Inc
Salt Lake City, UT |
SELL
|
- |
-1.27M- 75.2% |
$16.5M - $37M
|
418K
$3.93M
|
|
|
May 15, 2024
Q1 2024
|
Mpm Asset Management LLC
Cambridge, MA |
SELL
|
- |
-1.5M- 30.3% |
$19.6M - $43.8M
|
3.45M
$32.4M
|
|
|
Apr 12, 2024
Q1 2024
|
Vida Ventures Advisors, LLC
|
SELL
|
- |
-1.67M- 80.36% |
$21.8M - $48.7M
|
407K
$3.83M
|
|
|
May 03, 2024
Q1 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-1.87M- 18.87% |
$24.4M - $54.4M
|
8.02M
$75.4M
|